MDXG
MiMedx Group, Inc.Healthcare · $674M market cap
Verdict
Share price
$4.59
close of Oct 3, 2026
Fair value
$11.01
Sticker Price
Payback Price
$4.40
buy price
MDXG is Undervalued: at $4.59 it trades 58% below its fair value of $11.01. Its buy price (Payback Price) is $4.40, 4% below today's price. Business quality is strong: 4 of 5 key numbers clear the 10% bar.
How we valued it
Buffett Normalized. A profitable, growing business, so we project its earnings 10 years ahead and work out what that is worth today.
Business quality
4 of 5 clear the 10% bar. What are the Big Five?
Follow MDXG
Get notified when it reaches its buy price of $4.40. Free.
Create a free accountInsider activity
Since Jun 24, 2026: no open-market purchases and 2 other filings (stock awards, tax withholding and similar). Why purchases matter
Other filings
About MiMedx Group, Inc.
MiMedx Group, Inc. specializes in creating and supplying allografts derived from placental tissue, serving a diverse range of medical fields. The company employs its unique, patented PURION process to treat human placental tissues, a method crucial for manufacturing allografts that preserve the natural biological characteristics and essential regulatory proteins of the original tissue. This exclusive and patented…
Biotechnology
Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works